{"transactions":[{"id":820439,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-04-02T20:47:39.000Z","date":"2026-03-31","kind":"sale","planned":false,"acquired":false,"shares":2867,"price":2.5,"value":7167.5,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."}],"balance_after":195338,"source":{"system":"sec-edgar","filing":"0002057918-26-000007","document":"wk-form4_1775162856.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000205791826000007/wk-form4_1775162856.xml","form_type":"4"}},{"id":835452,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-18T20:06:54.000Z","date":"2026-03-16","kind":"sale","planned":false,"acquired":false,"shares":4835,"price":2.47,"value":11942.45,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.46 to $2.47, inclusive. The reporting person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth above."}],"balance_after":198205,"source":{"system":"sec-edgar","filing":"0001737287-26-000015","document":"wk-form4_1773864406.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728726000015/wk-form4_1773864406.xml","form_type":"4"}},{"id":862393,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-03-04T22:42:16.000Z","date":"2026-03-02","kind":"sale","planned":false,"acquired":false,"shares":7132,"price":2.6,"value":18543.2,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.60 to $2.67, inclusive. The reporting person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth above."}],"balance_after":203040,"source":{"system":"sec-edgar","filing":"0002057918-26-000003","document":"wk-form4_1772664133.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000205791826000003/wk-form4_1772664133.xml","form_type":"4"}},{"id":919754,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Restricted Stock Unit","published_at":"2026-02-04T22:20:22.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":105720,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Represents an award of Restricted Stock Units (RSUs). Each RSU represents a contingent right to receive one share of the Companys Common Stock. The RSUs will vest in 4 successive equal\nannual installments over the four-year period measured from February 2, 2026, subject to continued service through the vesting date."}],"balance_after":105720,"derivative":{"underlying":"Common Stock","underlying_shares":105720},"source":{"system":"sec-edgar","filing":"0001737287-26-000011","document":"wk-form4_1770243619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728726000011/wk-form4_1770243619.xml","form_type":"4"}},{"id":919753,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2026-02-04T22:20:22.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":373757,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to the stock option shall vest on February 2, 2027, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":373757,"derivative":{"exercise_price":1.87,"expiration_date":"2036-02-02","underlying":"Common Stock","underlying_shares":373757},"source":{"system":"sec-edgar","filing":"0001737287-26-000011","document":"wk-form4_1770243619.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728726000011/wk-form4_1770243619.xml","form_type":"4"}},{"id":919752,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2026-02-04T22:20:22.000Z","date":"2026-02-02","kind":"sale","planned":false,"acquired":false,"shares":7549,"price":1.73,"value":13059.77,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.71 to $1.75, inclusive. The reporting person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth above."}],"balance_after":210172,"source":{"system":"sec-edgar","filing":"0001737287-26-000011","document":"wk-form4_1770243619.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728726000011/wk-form4_1770243619.xml","form_type":"4"}},{"id":994244,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-11-19T21:09:26.000Z","date":"2025-11-17","kind":"sale","planned":false,"acquired":false,"shares":786,"price":1.22,"value":958.92,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plan to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.22 to $1.23, inclusive. The reporting person undertakes to\nprovide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price\nwithin the range set forth above."}],"balance_after":217721,"source":{"system":"sec-edgar","filing":"0001737287-25-000094","document":"wk-form4_1763586562.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728725000094/wk-form4_1763586562.xml","form_type":"4"}},{"id":1200834,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-03-18T21:28:04.000Z","date":"2025-03-14","kind":"sale","planned":false,"acquired":false,"shares":5488,"price":1.975,"value":10838.8,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares sold by the reporting person to cover tax withholding obligations in connection with the vesting of restricted stock units. This sale is mandated by the Issuer's election\nunder its equity incentive plant to require the satisfaction of tax withholding obligations to be funded by a \"sell to cover\" transaction and does not represent a discretionary trade by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in one transaction at the single price point of $1.975. The reporting person undertakes to\nprovide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at the price  set forth above."}],"balance_after":218507,"source":{"system":"sec-edgar","filing":"0001737287-25-000040","document":"wk-form4_1742333277.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728725000040/wk-form4_1742333277.xml","form_type":"4"}},{"id":1223267,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Stock Option (Right to buy)","published_at":"2025-03-05T21:11:13.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":112339,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to the stock option shall vest on March 1, 2026, and the remaining shares shall vest in 36 equal monthly installments thereafter."}],"balance_after":112339,"derivative":{"exercise_price":1.8,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":112339},"source":{"system":"sec-edgar","filing":"0001737287-25-000026","document":"wk-form4_1741209067.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728725000026/wk-form4_1741209067.xml","form_type":"4"}},{"id":1223266,"issuer":{"id":5243,"kind":"organization","name":"Allogene Therapeutics, Inc."},"owners":[{"id":54359,"kind":"person","name":"Beneski Benjamin Machinas","position":1,"cik":"0002057918","reported_name":"Beneski Benjamin Machinas","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Technical Officer"}}],"security":"Common Stock","published_at":"2025-03-05T21:11:13.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":31755,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":223995,"source":{"system":"sec-edgar","filing":"0001737287-25-000026","document":"wk-form4_1741209067.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2057918/000173728725000026/wk-form4_1741209067.xml","form_type":"4"}}]}